2. Learning and Growing with In-House Testing.
Keeping molecular testing in-house offers benefits for pathologists, oncologists, and patients.
Precision medicine is in its infancy, so continual development is key and every case deserves a thorough investigation. If you look at the molecular testing report without also having the opportunity to examine the raw data and interpret the results in context, you won’t be providing the best possible service – and you’ll be depriving yourself of the chance to learn and progress.
How does in-house testing contribute to better patient care?
The difference in turnaround times is hugely important. We are talking about patients for whom even a single day – let alone a week or two – can make a lifetime of difference. Often, oncologists ask for urgent results because their patients are deteriorating. Cancer doesn’t take weekends off. Whereas a central lab might take two weeks to provide those crucial results, in-house testing can be flexible and expedite delivery.
There’s also the question of potential sample loss. Sending FFPE tissue blocks to a central laboratory means taking on the risk of losing them. That can lead to tragedy because, often, one result is not enough;
Read the full article HERE.
